James Michael Krell MD

Dermatology•Birmingham, AL

Physician

Join to View Full Profile

1927 1st Ave NSte 200Birmingham, AL 35203
Phone+1 205-933-0987
Fax+1 205-930-1758

Education & Training

Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1989 - 1990
Harvard Medical SchoolClass of 1989

Certifications & Licensure

AL State Medical License 1993 - 2025
GA State Medical License 1990 - 2025
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
Completed
Phase 2
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Terminated
Phase 2
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata Start of enrollment: 2019 Jul 08
COMPLETED
PHASE3
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis Start of enrollment: 2019 Aug 12
Active, not recruiting
Phase 3
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Start of enrollment: 2020 Jun 04
Completed
Phase 2
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

3 citations
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.
Joel M Gelfand, April W Armstrong, Henry W Lim, Steven R Feldman, Sandra M Johnson
JAMA Dermatology. 2024-12-01
31 citations
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.
Bruce Strober, Bárður Sigurgeirsson, Georg Popp, Rodney Sinclair, James Krell
International Journal of Dermatology. 2016-04-01
2 citations
Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept
Charles Lynde, James Krell, Neil J. Korman, Barbara Mathes
Journal of the American Academy of Dermatology. 2011-10-01

Professional Memberships

American Academy of Dermatology - AAD
Fellow